vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Star Equity Holdings, Inc. (STRR). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $56.8M, roughly 1.1× Star Equity Holdings, Inc.). Star Equity Holdings, Inc. runs the higher net margin — -3.0% vs -70.9%, a 67.9% gap on every dollar of revenue. On growth, Star Equity Holdings, Inc. posted the faster year-over-year revenue change (69.0% vs 8.1%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-9.0M). Over the past eight quarters, Star Equity Holdings, Inc.'s revenue compounded faster (29.5% CAGR vs 17.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Artists Equity is an American production company founded by actors and filmmakers Ben Affleck and Matt Damon in November 2022.
CTKB vs STRR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $56.8M |
| Net Profit | $-44.1M | $-1.7M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | -0.2% |
| Net Margin | -70.9% | -3.0% |
| Revenue YoY | 8.1% | 69.0% |
| Net Profit YoY | -557.1% | -192.1% |
| EPS (diluted) | — | $-0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $56.8M | ||
| Q3 25 | $52.3M | $48.0M | ||
| Q2 25 | $45.6M | $35.5M | ||
| Q1 25 | $41.5M | $31.9M | ||
| Q4 24 | $57.5M | $33.6M | ||
| Q3 24 | $51.5M | $36.9M | ||
| Q2 24 | $46.6M | $35.7M | ||
| Q1 24 | $44.9M | $33.9M |
| Q4 25 | $-44.1M | $-1.7M | ||
| Q3 25 | $-5.5M | $-1.8M | ||
| Q2 25 | $-5.6M | $-688.0K | ||
| Q1 25 | $-11.4M | $-1.8M | ||
| Q4 24 | $9.6M | $-585.0K | ||
| Q3 24 | $941.0K | $-846.0K | ||
| Q2 24 | $-10.4M | $-441.0K | ||
| Q1 24 | $-6.2M | $-2.9M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | 43.0% | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | 50.5% | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | -0.2% | ||
| Q3 25 | -17.6% | -3.4% | ||
| Q2 25 | -23.3% | -0.6% | ||
| Q1 25 | -36.1% | -5.4% | ||
| Q4 24 | 5.2% | -0.4% | ||
| Q3 24 | -8.2% | -1.2% | ||
| Q2 24 | -18.3% | -0.5% | ||
| Q1 24 | -23.9% | -9.0% |
| Q4 25 | -70.9% | -3.0% | ||
| Q3 25 | -10.5% | -3.7% | ||
| Q2 25 | -12.2% | -1.9% | ||
| Q1 25 | -27.5% | -5.5% | ||
| Q4 24 | 16.8% | -1.7% | ||
| Q3 24 | 1.8% | -2.3% | ||
| Q2 24 | -22.4% | -1.2% | ||
| Q1 24 | -13.8% | -8.6% |
| Q4 25 | — | $-0.49 | ||
| Q3 25 | — | $-0.54 | ||
| Q2 25 | — | $-0.23 | ||
| Q1 25 | — | $-0.59 | ||
| Q4 24 | — | $-0.21 | ||
| Q3 24 | — | $-0.28 | ||
| Q2 24 | — | $-0.15 | ||
| Q1 24 | — | $-0.95 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $10.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $65.7M |
| Total Assets | $461.5M | $113.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $10.3M | ||
| Q3 25 | $93.3M | $15.4M | ||
| Q2 25 | $75.5M | $16.8M | ||
| Q1 25 | $95.3M | $16.6M | ||
| Q4 24 | $98.7M | $17.0M | ||
| Q3 24 | $162.3M | $15.8M | ||
| Q2 24 | $177.9M | $14.7M | ||
| Q1 24 | $168.8M | $20.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | $6.5M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $341.7M | $65.7M | ||
| Q3 25 | $378.6M | $67.8M | ||
| Q2 25 | $377.6M | $40.1M | ||
| Q1 25 | $379.6M | $39.5M | ||
| Q4 24 | $395.7M | $40.4M | ||
| Q3 24 | $385.5M | $42.9M | ||
| Q2 24 | $389.1M | $42.6M | ||
| Q1 24 | $392.6M | $44.3M |
| Q4 25 | $461.5M | $113.2M | ||
| Q3 25 | $494.9M | $117.1M | ||
| Q2 25 | $493.3M | $55.6M | ||
| Q1 25 | $482.6M | $53.2M | ||
| Q4 24 | $499.5M | $52.6M | ||
| Q3 24 | $491.2M | $52.6M | ||
| Q2 24 | $483.7M | $52.6M | ||
| Q1 24 | $492.1M | $52.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $-7.3M |
| Free Cash FlowOCF − Capex | $-1.8M | $-9.0M |
| FCF MarginFCF / Revenue | -2.9% | -15.8% |
| Capex IntensityCapex / Revenue | 1.6% | 3.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $-13.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $-7.3M | ||
| Q3 25 | $-3.9M | $-2.7M | ||
| Q2 25 | $108.0K | $139.0K | ||
| Q1 25 | $-125.0K | $-802.0K | ||
| Q4 24 | $2.0M | $-2.8M | ||
| Q3 24 | $13.2M | $1.3M | ||
| Q2 24 | $6.2M | $-4.3M | ||
| Q1 24 | $4.0M | $-1.8M |
| Q4 25 | $-1.8M | $-9.0M | ||
| Q3 25 | $-4.6M | $-3.4M | ||
| Q2 25 | $-1.5M | $102.0K | ||
| Q1 25 | $-974.0K | $-808.0K | ||
| Q4 24 | $1.1M | $-2.8M | ||
| Q3 24 | $12.2M | $1.3M | ||
| Q2 24 | $5.2M | $-4.3M | ||
| Q1 24 | $3.4M | $-1.8M |
| Q4 25 | -2.9% | -15.8% | ||
| Q3 25 | -8.7% | -7.0% | ||
| Q2 25 | -3.2% | 0.3% | ||
| Q1 25 | -2.3% | -2.5% | ||
| Q4 24 | 1.9% | -8.3% | ||
| Q3 24 | 23.7% | 3.4% | ||
| Q2 24 | 11.0% | -12.0% | ||
| Q1 24 | 7.6% | -5.3% |
| Q4 25 | 1.6% | 3.0% | ||
| Q3 25 | 1.3% | 1.3% | ||
| Q2 25 | 3.5% | 0.1% | ||
| Q1 25 | 2.0% | 0.0% | ||
| Q4 24 | 1.6% | 0.1% | ||
| Q3 24 | 2.0% | 0.0% | ||
| Q2 24 | 2.3% | 0.0% | ||
| Q1 24 | 1.3% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
STRR
| Revenue From Other Contracts With Customers | $27.6M | 49% |
| Other | $24.3M | 43% |
| Energy Services Segment | $4.9M | 9% |
